Skip to content
Hemispherx Biopharma, Inc. Logo
  • COMPANY
  • PRODUCTS
  • R & D
    • Product Candidates Overview
    • Pipeline
    • Orphan Drug Designations
  • PARTNERING
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • XBRL Filings
    • Stockholder Meeting
    • Corporate Governance
    • Email Alerts
    • Investor Contact
  • BLOG
  • CONTACT

Press Releases

 
Feb 07, 2005
HEMISPHERX BIOPHARMA EXPANDS EVALUATION OF ALFERON N AGAINST AVIAN FLU

Jan 03, 2005
HEMISPHERX BIOPHARMA INITIATES ENROLLMENT IN HIV/HEP-C CLINICAL PROGRAM

Dec 27, 2004
HEMISPHERX BIOPHARMA FILES LAWSUIT IN FEDERAL COURT ALLEGING CONSPIRACY BY FOREIGN NATIONALS TO MANIPULATE ITS STOCK PRICE AND ENGAGE IN ILLEGAL HOSTILE TAKEOVER

Dec 21, 2004
Los Angeles Times Article Focuses on Hemispherx Biopharma's Experimental Drug Ampligen as a Potential New Therapy for Chronic Fatigue Syndrome

Nov 22, 2004
HEMISPHERX BIOPHARMA INITIATES ALFERON LDO® CLINICAL PROGRAM IN COLLABORATION WITH PRINCESS MARGARET HOSPITAL IN HONG KONG

Nov 12, 2004
HEMISPHERX BIOPHARMA THIRD QUARTER 2004 EARNINGS ANNOUNCED

Nov 08, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE

Nov 01, 2004
Hemispherx Biopharma Presented New Data at the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, D.C.

Oct 25, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE RODMAN & RENSHAW TECHVEST 6TH ANNUAL HEALTHCARE CONFERENCE ON OCTOBER 27th

Oct 20, 2004
Unexpected Neurological Damage Spreads with West Nile Virus; Heightens Concern in Healthcare Community

 57   58   59   60   61     62    63   64   65   66   67 
 <<   <   >   >> 
Hemispherx Biopharma, Inc. Logo White

Latest News

  • CEO Roadshow Interviews Hemispherx Thomas K. Equels
  • Introducing You to the First Ampligen Quarterly Update
  • Proactive Investors USA Sits Down with Hemispherx CEO Thomas K. Equels

Privacy / Terms of Use

  • Terms Of Use
  • Investor Contact

Tweets by AIM Immuno

© Copyright | All Rights Reserved | AIM ImmunoTech Inc. | Privacy Policy | Terms of Use
FacebookTwitterYouTubeLinkedIn

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window